Skip to content

Clinical trials

Prostatic Hyperplasia trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: Australia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20071
20092
20102
20113
20132
20151
20181
20192
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting2
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Eli Lilly and Company2
Allergan1
Boston Scientific Corporation1
Light Sciences Oncology1
MedeonBio, Inc.1
NeoTract, Inc.1
PROCEPT BioRobotics1
Pfizer1
ProVerum Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia19
Lower Urinary Tract Symptoms6
Urinary Retention1

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.